Hansa Biopharma AB (publ) (STO:HNSA)

Hansa Biopharma AB Revenue

In the year 2024, Hansa Biopharma AB had annual revenue of 171.32M SEK with 27.76% growth. Hansa Biopharma AB had revenue of 32.34M in the quarter ending December 31, 2024, a decrease of -35.85%.

• Revenue: 171.32M
• Revenue Growth: +27.76%
• P/S Ratio: 8.25
• Revenue / Employee: 1.27M
• Employees: 135
• Market Cap: 1.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	171.32M	37.22M	27.76%
Dec 31, 2023	134.09M	-20.43M	-13.22%
Dec 31, 2022	154.53M	120.65M	356.12%
Dec 31, 2021	33.88M	27.78M	455.56%
Dec 31, 2020	6.10M	2.73M	81.27%